The UAB Cancer Center was selected as one of 30 cancer centers in the nation, and one of only five in the Southeast. The five-year grant, which awards $497,800 annually, allows the Cancer Center to be part of NCI's primary infrastructure to conduct state-of-the-art cancer treatment and advanced imaging clinical trials, especially large, definitive multi-institutional trials evaluating new cancer therapies and related clinical approaches for both adult and pediatric patients.
“MitraClip therapy is a groundbreaking treatment for mitral regurgitation, which is the most common type of heart valve insufficiency,” said Oluseun Alli, M.D., director of the structural heart program in the UAB School of Medicine Section of Interventional Cardiology. “This device is currently the only minimally invasive treatment we have for these high-risk patients, and it is the only device that has been effective in treating severe mitral regurgitation apart from open surgical repair or replacement.
“Very little is known about whether laws banning texting while driving have actually improved roadway safety,” UAB's Dr. Alva Ferdinand said. “Further, given the considerable variation in the types of laws that states have passed and whom they ban from what, it was necessary to determine which types of laws are most beneficial in improving roadway safety.”
"They're getting the experience they need to get plugged into that whole cyber security realm and maybe go work for Facebook," Director of UAB's "The Center" Dr. John Sloan said. "So we have folks that are working on developing new tools. We also have folks who are taking existing tools and then applying them in innovative ways to address cybersecurity issues."
More than 90 new Woodlawn High School 9th and 10th graders will get their school year off to a good start this week by taking part in special learning activities planned for them on the campuses of The University of Alabama at Birmingham (UAB) and Lawson State Community College.
As kids prepare to head back to school, required immunizations are typically on the to-do list, but getting potentially lifesaving vaccines should not end when adulthood begins, says one University of Alabama at Birmingham infectious diseases expert.